This wiki has undergone a migration to Confluence found Here
Difference between revisions of "2016-10-19PC DrugAllergySubstance Call Minutes"
Jump to navigation
Jump to search
(3 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
<!-- LOOK FOR THE APPROPRIATE SECTION ****** TO ENTER INFORMATION--> | <!-- LOOK FOR THE APPROPRIATE SECTION ****** TO ENTER INFORMATION--> | ||
− | Back to [[ | + | Back to [[Allergy_%26_Intolerance_Drug_Sub-project]] |
==Minutes Template== | ==Minutes Template== | ||
===Meeting Information=== | ===Meeting Information=== | ||
Line 97: | Line 97: | ||
'''Minutes/Conclusions Reached:'''<br/> | '''Minutes/Conclusions Reached:'''<br/> | ||
* Netherlands working with ISO on drug safety db [https://www.knmp.nl/producten-en-diensten/gebruiksrecht-g-standaard/informatie-over-de-g-standaard/the-g-standaard-the-medicines-standard-in-healthcare here] | * Netherlands working with ISO on drug safety db [https://www.knmp.nl/producten-en-diensten/gebruiksrecht-g-standaard/informatie-over-de-g-standaard/the-g-standaard-the-medicines-standard-in-healthcare here] | ||
+ | * Note: use case is patient safety, not adverse event reporting | ||
+ | * Record what you know; so if Percocet is the trigger, record "acetaminophen and oxycodone." You can't choose one. | ||
+ | * Confirm: inactive ingredient reactions are very rare; our list will only include active ingredients | ||
+ | * A clinician may record a specific product, but the substance is what goes in the allergy list | ||
+ | * Questions on site discussed. Most are TBD. | ||
+ | * How do we map? | ||
+ | ** Ask VA/DoD team to present | ||
+ | * What system? | ||
+ | ** SCT does not have MINs in substance hierarchy | ||
+ | ** Ask Larry to present IDMP | ||
===Meeting Outcomes=== | ===Meeting Outcomes=== | ||
Line 112: | Line 122: | ||
| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' '' | | width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' '' | ||
+ | * Jay to invite contributors | ||
− | |||
|- | |- | ||
Line 127: | Line 137: | ||
|width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | |width="100%" |'''Next Meeting/Preliminary Agenda Items'''<br/> | ||
− | * | + | * get those who have mapped to describe process |
+ | * become familiar with candidate systems | ||
|} | |} | ||
© 2012 Health Level Seven® International. All rights reserved. | © 2012 Health Level Seven® International. All rights reserved. |
Latest revision as of 14:00, 19 October 2016
Back to Allergy_&_Intolerance_Drug_Sub-project
Minutes Template
Meeting Information
HL7 Negation Requirements Meeting Minutes Location: Phone |
Date: 2016-10-19 Time: 9:00-10:00 ET | ||
Facilitator | Jay Lyle | Note taker(s) | Jay Lyle |
Attendee | Name | Affiliation
| |
y | Jay Lyle | JP Systems / VA | |
y | Froukje Harkes-Idzinga | Nictiz | |
y | Rob Hausam | Hausam Consulting | |
y | Serafina Versaggi | Versaggi Consulting | |
y | Joe Quinn | Optum | |
Agenda
Agenda Topics
- confirm goals
- address open questions
- identify gaps & tasks
Minutes
Minutes/Conclusions Reached:
- Netherlands working with ISO on drug safety db here
- Note: use case is patient safety, not adverse event reporting
- Record what you know; so if Percocet is the trigger, record "acetaminophen and oxycodone." You can't choose one.
- Confirm: inactive ingredient reactions are very rare; our list will only include active ingredients
- A clinician may record a specific product, but the substance is what goes in the allergy list
- Questions on site discussed. Most are TBD.
- How do we map?
- Ask VA/DoD team to present
- What system?
- SCT does not have MINs in substance hierarchy
- Ask Larry to present IDMP
Meeting Outcomes
Actions
|
Next Meeting/Preliminary Agenda Items
|
© 2012 Health Level Seven® International. All rights reserved.